Choose test
Where to pass the test?
Test from the National Health Service
Loyalty program
Nurse visit
For clients
  • Screening 40+
  • Wallet
  • Special offers
  • Partner offers
  • Preparing a child for tests
  • Doctors’ consultations
  • Cytological passport
  • FAQ
  • “Be Healthy” portal
Laboratory
  • News
  • About us
  • Equipment
  • Licenses and certificates
  • Leadership
  • Career
  • Contacts
For doctor
  • Information for doctors
Business
  • Tissue diagnostics
  • Cooperation with Synevo
  • Business Cabinet
  1. Home
  2. Tests sections
  3. 1026. Tumor marker of pancreas, gallbladder (CA 19-9)

All test sections

Choose the category you’re interested in

TOP tests

What to check

Heart and blood vesselsSugar and metabolismThyroid glandImmunityInfectionsWomen's and men's healthTumor markersLiver and kidneysVitamins and trace elementsAllergensBlood type and Rh factorGenetic testsSkin, Hair, and Nails

Diseases

Cardiovascular diseasesDiabetes mellitus and metabolismThyroid gland and hormonal disordersInfectious diseasesAnemia and blood diseasesAllergies and immunological conditionsUrogenital infections and STDsTORCH infectionsPathology of pregnancyOncology and tumor screeningObesity and endocrine disordersHepatitis and liver diseasesGastroenterology and the gastrointestinal tractInflammatory and rheumatic diseasesRenal failure and kidney diseasesNeurological disordersTuberculosisWorms and parasitic infestationsGenetic diseases and mutation carriageCeliac disease and food intoleranceHealth of skin, hair and nails

For whom

For womenFor menFor childrenFor the elderlyWhen planning a pregnancy For pregnant womenBefore surgeryFor athletes and active peopleFor beautyFor vegetarians and vegans

Check-up

Women'sMen'sChildren'sFor the elderlyCardiovascularHormonalMetabolism and diabetesSkin, Hair and Nail HealthImmune and InfectiousOncologyVitamins and MineralsReproductive HealthAnnual PreventiveSpecializedAdvanced

Panels

General clinicalThyroid panelPhosphorus-calcium metabolismReproductive panelHypothalamic-pituitary-adrenal axisCarbohydrate metabolismPrenatal diagnosticsKaryotypingOncology panelOther infectionsHepatitisTorch infectionsUrogenital infectionsCoronavirus SARS-CoV-2Parasitic infectionsHivLyme disease (borreliosis)Helicobacter pyloriTuberculosisAutoimmunological panelImmunological causes of infertilityCeliac diseaseRheumatological panelGeneral immunologyAntiphospholipid syndromeBacteriological panelCytological panelPathomorphological panelBiochemical panelVitaminsAnemiaCardiovascular disease markersAcute phase markersTherapeutic drug monitoringHeavy metalsAmino acids. Organic acidsGenetic panelScreening packagesAllergological panel

Biomaterial

Blood ScrapingUrineFeces Sperm SalivaProstate secretSmear / Bacterial culturePlacenta / amniotic fluidBile / breast milkLiquorPathomorphologyCytology on glass

1026. Tumor marker of pancreas, gallbladder (CA 19-9)

1026. Tumor marker of pancreas, gallbladder (CA 19-9)

Turnaround time (days): 1

465 ₴

Description

Pancreatic and gallbladder tumor marker (CA 19-9) is a tumor marker used to diagnose and monitor pancreatic cancer. Its levels may also increase in liver, stomach, and intestinal tumors, so it is recommended to measure it in combination with CA 50, CA 242, and PEA.

The pancreatic and gallbladder tumor marker (CA 19-9) (cancer-associated carbohydrate antigen) is a ahigh-molecular-weight glycoprotein normally synthesized by epithelial cells of the gastrointestinal tract, biliary system, salivary glands, and lungs. Its blood level increases significantly in the presence of malignant tumors, especially cancer of the pancreas, gallbladder, biliary tract, stomach, colon, and rectum.

The CA 19-9 tumor marker has high diagnostic sensitivity. It is used primarily not for initial diagnosis, but to assess disease progression, monitor treatment effectiveness, and detect relapses and metastases.

However, approximately 5-7% of people, due to genetic factors (the absence of the so-called Lewis antigen), do not synthesize CA 19-9, even in the presence of a tumor. In such cases, the test result may be false negative, therefore, to increase the accuracy of diagnosis, it must be interpreted in combination with other tumor markers – CA 50, CA 242, CA 72-4, REA, etc.

When and who needs the test?

  • For suspected pancreatic cancer, in combination with CA 50.
  • For preclinical diagnosis of metastasis.
  • For suspected colorectal cancer (in combination with REA).
  • For differential diagnosis of mucinous ovarian tumors – in combination with CA 125 and HE4.
  • To assess treatment effectiveness and monitor the progression of the disease (pancreatic and gastric cancer).

Biological material

  • Venous blood

Preparing for a blood test

In order to exclude factors that may affect the test results, we recommend to follow the preparation rules:

  • an important condition for laboratory tests is to take blood on an empty stomach.
  • 6-12 hours before the test, you should avoid eating, drinking alcohol, smoking, and limit physical activity. Drinking...

Cheaper in a package

1132. Package # 7.1 (Female oncology screening)

Number of tests: 5
Carcinoembryonic antigen (CEA)
Tumor marker of ovaries (CA 125)

Turnaround time (days): 1

1960 ₴

1133. Package # 7.2 (Male oncology screening )

Number of tests: 5
α-fetoprotein (AFP)
Carcinoembryonic antigen (CEA)

Turnaround time (days): 1

2120 ₴

1216. Package # 7.4 (Female oncology screening 2)

Number of tests: 7
Calculation of the risk of ovarian cancer (Index ROMA, %)
Tumor marker HE4

Turnaround time (days): 1

2690 ₴

1963. Package # 440 (Determining the risk of cancer development in a man)

Number of tests: 9
Ratio of free PSA to total PSA
α-fetoprotein (AFP)

Turnaround time (days): 1

3740 ₴

1026. Tumor marker of pancreas, gallbladder (CA 19-9)

465 ₴

Information service

0 800 60 55 00

Free from mobile and stationary operators in Ukraine (except for the temporarily occupied territories)

Our social media

Media inquiries contacts

press@synevo.ua

About Us

About us
Career
News
Contacts

Customers

Choose test
Where to pass the test?
Get results
Special offers
“Be Healthy” portal

Legal information

Public contract
Loyalty program rules
Financial statements
Licenses and certificates
Tender
Legal conditions of special offers
Providing services to minors
Synevo, 2026